BP
Publicaties op Oncologisch.com
Fase II Dose-Gerandomiseerde Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal ...
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.
A Multicenter Open-Label Gerandomiseerde Fase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase...